Cynosure Inc (NASDAQ:CYNO)
| 23.98 Data as of May 22 |  -0.86 / -3.46%Today’s Change | 18.37 Today|||52-Week Range 30.20 | -0.54% Year-to-Date |
Latest CYNO News | Press Releases
| Cynosure Enters Oversold Territory (CYNO) May 20 / TheStreet.com |
Today’s Trading
| Previous close | 24.84 |
| Today’s open | 24.94 |
| Day’s range | 23.74 - 25.00 |
| Volume | 118,283 |
| Average volume (3 months) | 188,777 |
| Market cap | $402.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3.36% |
| Earnings growth (next 5 years) | +90.00% |
| Revenue growth (last year) | +38.78% |
| P/E ratio | 30.4 |
| Price/Sales | 2.07 |
| Price/Book | 2.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARAYAccuray Inc | -0.21 | -3.81% |
| IVCInvacare Corp | -0.42 | -2.87% |
| TEARTearLab Corp | -0.08 | -0.83% |
| IMMUImmunomedics Inc | -0.01 | -0.32% |
Data as of 4:05pm ET, 05/22/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.19 |
| Annual revenue (last year) | $153.5M |
| Annual profit (last year) | $11.0M |
| Net profit margin | 7.14% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Davin |
Executive Vice President- Operations David Mackie |
Corporate headquarters Westford, Massachusetts |
Forecasts
